Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTAW) Asset Writedowns and Impairment (2023 - 2025)

Historic Asset Writedowns and Impairment for Strata Critical Medical (SRTAW) over the last 3 years, with Q3 2025 value amounting to -$385000.0.

  • Strata Critical Medical's Asset Writedowns and Impairment changed N/A to -$385000.0 in Q3 2025 from the same period last year, while for Jun 2025 it was $385000.0, marking a year-over-year decrease of 9854.78%. This contributed to the annual value of $5.8 million for FY2024, which is 7224.98% down from last year.
  • Strata Critical Medical's Asset Writedowns and Impairment amounted to -$385000.0 in Q3 2025.
  • Strata Critical Medical's Asset Writedowns and Impairment's 5-year high stood at $20.6 million during Q4 2023, with a 5-year trough of -$385000.0 in Q3 2025.
  • For the 3-year period, Strata Critical Medical's Asset Writedowns and Impairment averaged around $3.8 million, with its median value being $171000.0 (2023).
  • Examining YoY changes over the last 5 years, Strata Critical Medical's Asset Writedowns and Impairment showed a top increase of 322.58% in 2025 and a maximum decrease of 9380.24% in 2025.
  • Strata Critical Medical's Asset Writedowns and Impairment (Quarter) stood at $20.6 million in 2023, then tumbled by 72.17% to $5.7 million in 2024, then crashed by 106.72% to -$385000.0 in 2025.
  • Its last three reported values are -$385000.0 in Q3 2025, $355000.0 for Q2 2025, and $30000.0 during Q1 2025.